14.92
14.92 (0%)
As of Feb 14, 2025
Syndax Pharmaceuticals Inc [SNDX]
Source:
Company Overview
Syndax Pharmaceuticals Inc is a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies. We currently have two commercially approved medicines and a robust slate of clinical development programs designed to unlock the full potential of our first two medicines.
Country | United States |
Headquarters | waltham, massachusetts |
Phone Number | 781-419-1400 |
Industry | manufacturing |
CEO | Michael A. Metzger |
Website | www.syndax.com |